choline has been researched along with Angiogenesis, Pathologic in 14 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study choline metabolism in biopsies from nonenhancing Grade 2 (AS2) and Grade 3 (AS3) astrocytomas to determine whether (1) phosphocholine (PC) dominates in AS3, and (2) PC is associated with proliferation or angiogenesis." | 7.77 | Choline metabolism, proliferation, and angiogenesis in nonenhancing grades 2 and 3 astrocytoma. ( Berger, MS; Chang, SM; Chiu, KS; Chu, PW; Cloyd, CP; McKnight, TR; Phillips, JJ; Smith, KJ, 2011) |
| " The aim of this study was to determine uptake of the (18)F-labeled PET tracers (18)F-fluorocholine (N,N-dimethyl-N-(18)F-fluoromethyl-2-hydroxyethylammonium), (18)F-fluoro-ethyl-l-tyrosine (FET), and (18)F-FDG in C6 gliomas of the rat and to correlate it with uptake of the anti-extra domain B antibody (131)I-SIP(L19) as a marker of neoangiogenesis." | 7.74 | Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis. ( Alessi, P; Biollaz, G; Buck, A; Neri, D; Pahnke, J; Spaeth, N; Trachsel, E; Treyer, V; Weber, B; Wyss, MT, 2007) |
| "Gliomas are characterized by intratumoral histological heterogeneity, coexisting foci of low and high grade." | 5.56 | Low-Grade Versus High-Grade Glioma… That Is the Question. 18F-Fluorocholine PET in the Detection of Anaplastic Focus. ( Borrás Moreno, JM; Cordero García, JM; García Vicente, AM; López Menéndez, C; Soriano Castrejón, A, 2020) |
| "Thirteen patients with recurrent glioblastoma were enrolled in RTOG 0625/ACRIN 6677, a prospective multicenter trial in which bevacizumab was used in combination with either temozolomide or irinotecan." | 5.17 | Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677. ( Barboriak, DP; Bokstein, F; Boxerman, JL; Gilbert, MR; McKinstry, RC; Ratai, EM; Safriel, Y; Snyder, BS; Sorensen, AG; Zhang, Z, 2013) |
| "To study choline metabolism in biopsies from nonenhancing Grade 2 (AS2) and Grade 3 (AS3) astrocytomas to determine whether (1) phosphocholine (PC) dominates in AS3, and (2) PC is associated with proliferation or angiogenesis." | 3.77 | Choline metabolism, proliferation, and angiogenesis in nonenhancing grades 2 and 3 astrocytoma. ( Berger, MS; Chang, SM; Chiu, KS; Chu, PW; Cloyd, CP; McKnight, TR; Phillips, JJ; Smith, KJ, 2011) |
| " The aim of this study was to determine uptake of the (18)F-labeled PET tracers (18)F-fluorocholine (N,N-dimethyl-N-(18)F-fluoromethyl-2-hydroxyethylammonium), (18)F-fluoro-ethyl-l-tyrosine (FET), and (18)F-FDG in C6 gliomas of the rat and to correlate it with uptake of the anti-extra domain B antibody (131)I-SIP(L19) as a marker of neoangiogenesis." | 3.74 | Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis. ( Alessi, P; Biollaz, G; Buck, A; Neri, D; Pahnke, J; Spaeth, N; Trachsel, E; Treyer, V; Weber, B; Wyss, MT, 2007) |
| "We evaluated the effects of angiogenesis inhibitor, TNP-470, on hepatocellular carcinoma (HCCs) induced by a choline-deficient L-amino acid defined (CDAA) diet in rats." | 3.70 | Angiogenesis inhibitor TNP-470 suppresses the progression of experimentally-induced hepatocellular carcinoma in rats. ( Kin, M; Nakamura, T; Ogata, R; Sakamoto, M; Sata, M; Tamaki, S; Torimura, T; Ueno, T, 2000) |
| "Gliomas are characterized by intratumoral histological heterogeneity, coexisting foci of low and high grade." | 1.56 | Low-Grade Versus High-Grade Glioma… That Is the Question. 18F-Fluorocholine PET in the Detection of Anaplastic Focus. ( Borrás Moreno, JM; Cordero García, JM; García Vicente, AM; López Menéndez, C; Soriano Castrejón, A, 2020) |
| "Choline SNR was significantly different (P < 0." | 1.33 | Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. ( Argani, P; Barker, PB; Bhujwalla, ZM; Bluemke, DA; Jacobs, MA; Ouwerkerk, R, 2005) |
| "Nonalcoholic steatohepatitis (NASH) may cause fibrosis, cirrhosis, and hepatocellular carcinoma (HCC); however, the exact mechanism of disease progression is not fully understood." | 1.33 | Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats. ( Akahane, T; Asada, K; Fukui, H; Ikenaka, Y; Kaji, K; Kitade, M; Kojima, H; Namisaki, T; Noguchi, R; Tsujimoto, T; Uemura, M; Yamazaki, M; Yanase, K; Yoshii, J; Yoshiji, H, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (71.43) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| García Vicente, AM | 1 |
| Cordero García, JM | 1 |
| López Menéndez, C | 1 |
| Borrás Moreno, JM | 1 |
| Soriano Castrejón, A | 1 |
| Ratai, EM | 1 |
| Zhang, Z | 1 |
| Snyder, BS | 1 |
| Boxerman, JL | 1 |
| Safriel, Y | 1 |
| McKinstry, RC | 1 |
| Bokstein, F | 1 |
| Gilbert, MR | 1 |
| Sorensen, AG | 1 |
| Barboriak, DP | 1 |
| Gauthier, H | 1 |
| Law, M | 1 |
| Weber, MA | 1 |
| Henze, M | 1 |
| Tüttenberg, J | 1 |
| Stieltjes, B | 1 |
| Meissner, M | 1 |
| Zimmer, F | 1 |
| Burkholder, I | 1 |
| Kroll, A | 1 |
| Combs, SE | 1 |
| Vogt-Schaden, M | 1 |
| Giesel, FL | 1 |
| Zoubaa, S | 1 |
| Haberkorn, U | 1 |
| Kauczor, HU | 1 |
| Essig, M | 1 |
| McKnight, TR | 1 |
| Smith, KJ | 1 |
| Chu, PW | 1 |
| Chiu, KS | 1 |
| Cloyd, CP | 1 |
| Chang, SM | 2 |
| Phillips, JJ | 1 |
| Berger, MS | 1 |
| Cook, GJ | 1 |
| Jacobs, MA | 1 |
| Barker, PB | 1 |
| Argani, P | 1 |
| Ouwerkerk, R | 1 |
| Bhujwalla, ZM | 1 |
| Bluemke, DA | 1 |
| Kitade, M | 1 |
| Yoshiji, H | 1 |
| Kojima, H | 1 |
| Ikenaka, Y | 1 |
| Noguchi, R | 1 |
| Kaji, K | 1 |
| Yoshii, J | 1 |
| Yanase, K | 1 |
| Namisaki, T | 1 |
| Asada, K | 1 |
| Yamazaki, M | 1 |
| Tsujimoto, T | 1 |
| Akahane, T | 1 |
| Uemura, M | 1 |
| Fukui, H | 1 |
| Wyss, MT | 1 |
| Spaeth, N | 1 |
| Biollaz, G | 1 |
| Pahnke, J | 1 |
| Alessi, P | 1 |
| Trachsel, E | 1 |
| Treyer, V | 1 |
| Weber, B | 1 |
| Neri, D | 1 |
| Buck, A | 1 |
| Zonari, P | 1 |
| Baraldi, P | 1 |
| Crisi, G | 1 |
| Bulakbasi, N | 1 |
| Kocaoglu, M | 1 |
| Sanal, TH | 1 |
| Tayfun, C | 1 |
| Kin, M | 1 |
| Torimura, T | 1 |
| Ueno, T | 1 |
| Nakamura, T | 1 |
| Ogata, R | 1 |
| Sakamoto, M | 1 |
| Tamaki, S | 1 |
| Sata, M | 1 |
| Henry, RG | 1 |
| Vigneron, DB | 1 |
| Fischbein, NJ | 1 |
| Grant, PE | 1 |
| Day, MR | 1 |
| Noworolski, SM | 1 |
| Star-Lack, JM | 1 |
| Wald, LL | 1 |
| Dillon, WP | 1 |
| Nelson, SJ | 1 |
3 reviews available for choline and Angiogenesis, Pathologic
| Article | Year |
|---|---|
[Positron emission tomography and evaluation of response to targeted therapies].
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Hypoxia; Cell Proliferation; Choline; ErbB Recept | 2009 |
Advanced imaging techniques in brain tumors.
Topics: Angiogenesis Inhibitors; Biopsy; Brain Chemistry; Brain Neoplasms; Capillary Permeability; Choline; | 2009 |
Oncological molecular imaging: nuclear medicine techniques.
Topics: Apoptosis; Cell Division; Choline; Gene Expression; Genetic Therapy; Glycolysis; Humans; Hypoxia; Ne | 2003 |
1 trial available for choline and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Be | 2013 |
10 other studies available for choline and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Low-Grade Versus High-Grade Glioma… That Is the Question. 18F-Fluorocholine PET in the Detection of Anaplastic Focus.
Topics: Brain Neoplasms; Choline; Glioma; Humans; Magnetic Resonance Imaging; Neoplasm Grading; Neovasculari | 2020 |
Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Biopsy; Brain Neoplasms; Choline; Contras | 2010 |
Choline metabolism, proliferation, and angiogenesis in nonenhancing grades 2 and 3 astrocytoma.
Topics: Adult; Astrocytoma; Biopsy; Brain Neoplasms; Cell Proliferation; Choline; Female; Glioma; Glycerylph | 2011 |
Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study.
Topics: Breast; Breast Neoplasms; Choline; Contrast Media; Feasibility Studies; Female; Gadolinium DTPA; Hum | 2005 |
Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats.
Topics: Animals; Carcinoma, Hepatocellular; Choline; Disease Models, Animal; Disease Progression; Fatty Live | 2006 |
Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis.
Topics: Animals; Antibodies; Brain Neoplasms; Cell Line, Tumor; Choline; Fibronectins; Glioma; Male; Neovasc | 2007 |
Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Biopsy; Blood Flow Velocity; Brain; Brain Neoplasms; Choline | 2007 |
Dysembryoplastic neuroepithelial tumors: proton MR spectroscopy, diffusion and perfusion characteristics.
Topics: Adolescent; Adult; Blood Flow Velocity; Choline; Creatine; Diagnosis, Differential; Diffusion Magnet | 2007 |
Angiogenesis inhibitor TNP-470 suppresses the progression of experimentally-induced hepatocellular carcinoma in rats.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Carcinoma, Hepatocellular; Choline; Cyclohexanes; Diet; | 2000 |
Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas.
Topics: Adult; Aspartic Acid; Blood Volume; Brain; Brain Neoplasms; Choline; Combined Modality Therapy; Fema | 2000 |